ALDR
Alder Biopharmaceuticals
ALDR
ALDR
Delisted
ALDR was delisted on the 21st of October, 2019.
124 hedge funds and large institutions have $733M invested in Alder Biopharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 39 increasing their positions, 36 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
62% less call options, than puts
Call options by funds: $253K | Put options by funds: $673K
Holders
124
Holding in Top 10
2
Calls
$253K
Puts
$673K
Top Buyers
| 1 | +$16.1M | |
| 2 | +$9.27M | |
| 3 | +$6.41M | |
| 4 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$5.13M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$5.02M |
Top Sellers
| 1 | -$31.9M | |
| 2 | -$16.7M | |
| 3 | -$8.55M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$4.93M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.86M |